Emergence times are similar with sevoflurane and total intravenous anesthesia: Results of a multicenter rct of patients scheduled for elective supratentorial craniotomy

Enrico Lauta, Crescenza Abbinante, Alfredo Del Gaudio, Fulvio Aloj, Margherita Fanelli, Paolo De Vivo, Concezione Tommasino, Tommaso Fiore

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Nearly every anesthetic agent has been used for craniotomy, yet the choice between intravenous or volatile agents has been considered an area of significant debate in neuroanesthesia. We designed a Randomized Clinical Trial to test the hypothesis that inhalation anesthesia (sevoflurane/ remifentanil-group S) reduces emergence time by 5 minutes compared with intravenous anesthesia (propofol/remifentanil-group P) in patients undergoing neurosurgery for supratentorial neoplasms. METHODS: Adult ASA I-III elective patients were randomly assigned to group S or P. The primary outcome was time to reach an Aldrete test score (AS) of more than equal to 9; secondary outcomes were times to eyes opening (TEO) and extubation (ET), adverse events, intraoperative hemodynamics, brain relaxation score (BRS), opioid consumption, and diuresis. RESULTS: No significant differences were found between S (n=149) and P (n=153) treatments in primary outcomes: median time to reach AS=9 was 5 minutes (25th to 75th percentile 5 to 10 minutes in both groups, P ≥ 0.05); and 15 minutes to reach AS=10 (P group 95% CI=10.3-19.7 min; S group 95% CI=11.4-18.5min, P ≥ 0.05) in both groups.TEO and ET expressed as median values (95% CI) were, respectively: 8 (6.8 to 9.2) minutes in group P versus 6 (4.6 to 7.4) in group S, P

Original languageEnglish
Pages (from-to)110-118
Number of pages9
JournalJournal of Neurosurgical Anesthesiology
Volume22
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Intravenous Anesthesia
Craniotomy
Supratentorial Neoplasms
Inhalation Anesthesia
Diuresis
Neurosurgery
Propofol
Opioid Analgesics
Anesthetics
Randomized Controlled Trials
Hemodynamics
sevoflurane
Brain
remifentanil
Therapeutics

Keywords

  • Craniotomy
  • Inhalation anesthesia
  • Intravenous anesthesia
  • Neurosurgery
  • Neurosurgical anesthesia
  • Propofol
  • Sevoflurane
  • Superiority clinical trial
  • Supratentorial neoplasms

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Surgery

Cite this

Emergence times are similar with sevoflurane and total intravenous anesthesia : Results of a multicenter rct of patients scheduled for elective supratentorial craniotomy. / Lauta, Enrico; Abbinante, Crescenza; Gaudio, Alfredo Del; Aloj, Fulvio; Fanelli, Margherita; De Vivo, Paolo; Tommasino, Concezione; Fiore, Tommaso.

In: Journal of Neurosurgical Anesthesiology, Vol. 22, No. 2, 04.2010, p. 110-118.

Research output: Contribution to journalArticle

Lauta, Enrico ; Abbinante, Crescenza ; Gaudio, Alfredo Del ; Aloj, Fulvio ; Fanelli, Margherita ; De Vivo, Paolo ; Tommasino, Concezione ; Fiore, Tommaso. / Emergence times are similar with sevoflurane and total intravenous anesthesia : Results of a multicenter rct of patients scheduled for elective supratentorial craniotomy. In: Journal of Neurosurgical Anesthesiology. 2010 ; Vol. 22, No. 2. pp. 110-118.
@article{81bbf9bc051b4e9ab6a53244974d6d5d,
title = "Emergence times are similar with sevoflurane and total intravenous anesthesia: Results of a multicenter rct of patients scheduled for elective supratentorial craniotomy",
abstract = "BACKGROUND: Nearly every anesthetic agent has been used for craniotomy, yet the choice between intravenous or volatile agents has been considered an area of significant debate in neuroanesthesia. We designed a Randomized Clinical Trial to test the hypothesis that inhalation anesthesia (sevoflurane/ remifentanil-group S) reduces emergence time by 5 minutes compared with intravenous anesthesia (propofol/remifentanil-group P) in patients undergoing neurosurgery for supratentorial neoplasms. METHODS: Adult ASA I-III elective patients were randomly assigned to group S or P. The primary outcome was time to reach an Aldrete test score (AS) of more than equal to 9; secondary outcomes were times to eyes opening (TEO) and extubation (ET), adverse events, intraoperative hemodynamics, brain relaxation score (BRS), opioid consumption, and diuresis. RESULTS: No significant differences were found between S (n=149) and P (n=153) treatments in primary outcomes: median time to reach AS=9 was 5 minutes (25th to 75th percentile 5 to 10 minutes in both groups, P ≥ 0.05); and 15 minutes to reach AS=10 (P group 95{\%} CI=10.3-19.7 min; S group 95{\%} CI=11.4-18.5min, P ≥ 0.05) in both groups.TEO and ET expressed as median values (95{\%} CI) were, respectively: 8 (6.8 to 9.2) minutes in group P versus 6 (4.6 to 7.4) in group S, P",
keywords = "Craniotomy, Inhalation anesthesia, Intravenous anesthesia, Neurosurgery, Neurosurgical anesthesia, Propofol, Sevoflurane, Superiority clinical trial, Supratentorial neoplasms",
author = "Enrico Lauta and Crescenza Abbinante and Gaudio, {Alfredo Del} and Fulvio Aloj and Margherita Fanelli and {De Vivo}, Paolo and Concezione Tommasino and Tommaso Fiore",
year = "2010",
month = "4",
doi = "10.1097/ANA.0b013e3181c959da",
language = "English",
volume = "22",
pages = "110--118",
journal = "Journal of Neurosurgical Anesthesiology",
issn = "0898-4921",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Emergence times are similar with sevoflurane and total intravenous anesthesia

T2 - Results of a multicenter rct of patients scheduled for elective supratentorial craniotomy

AU - Lauta, Enrico

AU - Abbinante, Crescenza

AU - Gaudio, Alfredo Del

AU - Aloj, Fulvio

AU - Fanelli, Margherita

AU - De Vivo, Paolo

AU - Tommasino, Concezione

AU - Fiore, Tommaso

PY - 2010/4

Y1 - 2010/4

N2 - BACKGROUND: Nearly every anesthetic agent has been used for craniotomy, yet the choice between intravenous or volatile agents has been considered an area of significant debate in neuroanesthesia. We designed a Randomized Clinical Trial to test the hypothesis that inhalation anesthesia (sevoflurane/ remifentanil-group S) reduces emergence time by 5 minutes compared with intravenous anesthesia (propofol/remifentanil-group P) in patients undergoing neurosurgery for supratentorial neoplasms. METHODS: Adult ASA I-III elective patients were randomly assigned to group S or P. The primary outcome was time to reach an Aldrete test score (AS) of more than equal to 9; secondary outcomes were times to eyes opening (TEO) and extubation (ET), adverse events, intraoperative hemodynamics, brain relaxation score (BRS), opioid consumption, and diuresis. RESULTS: No significant differences were found between S (n=149) and P (n=153) treatments in primary outcomes: median time to reach AS=9 was 5 minutes (25th to 75th percentile 5 to 10 minutes in both groups, P ≥ 0.05); and 15 minutes to reach AS=10 (P group 95% CI=10.3-19.7 min; S group 95% CI=11.4-18.5min, P ≥ 0.05) in both groups.TEO and ET expressed as median values (95% CI) were, respectively: 8 (6.8 to 9.2) minutes in group P versus 6 (4.6 to 7.4) in group S, P

AB - BACKGROUND: Nearly every anesthetic agent has been used for craniotomy, yet the choice between intravenous or volatile agents has been considered an area of significant debate in neuroanesthesia. We designed a Randomized Clinical Trial to test the hypothesis that inhalation anesthesia (sevoflurane/ remifentanil-group S) reduces emergence time by 5 minutes compared with intravenous anesthesia (propofol/remifentanil-group P) in patients undergoing neurosurgery for supratentorial neoplasms. METHODS: Adult ASA I-III elective patients were randomly assigned to group S or P. The primary outcome was time to reach an Aldrete test score (AS) of more than equal to 9; secondary outcomes were times to eyes opening (TEO) and extubation (ET), adverse events, intraoperative hemodynamics, brain relaxation score (BRS), opioid consumption, and diuresis. RESULTS: No significant differences were found between S (n=149) and P (n=153) treatments in primary outcomes: median time to reach AS=9 was 5 minutes (25th to 75th percentile 5 to 10 minutes in both groups, P ≥ 0.05); and 15 minutes to reach AS=10 (P group 95% CI=10.3-19.7 min; S group 95% CI=11.4-18.5min, P ≥ 0.05) in both groups.TEO and ET expressed as median values (95% CI) were, respectively: 8 (6.8 to 9.2) minutes in group P versus 6 (4.6 to 7.4) in group S, P

KW - Craniotomy

KW - Inhalation anesthesia

KW - Intravenous anesthesia

KW - Neurosurgery

KW - Neurosurgical anesthesia

KW - Propofol

KW - Sevoflurane

KW - Superiority clinical trial

KW - Supratentorial neoplasms

UR - http://www.scopus.com/inward/record.url?scp=77949986594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949986594&partnerID=8YFLogxK

U2 - 10.1097/ANA.0b013e3181c959da

DO - 10.1097/ANA.0b013e3181c959da

M3 - Article

C2 - 20308817

AN - SCOPUS:77949986594

VL - 22

SP - 110

EP - 118

JO - Journal of Neurosurgical Anesthesiology

JF - Journal of Neurosurgical Anesthesiology

SN - 0898-4921

IS - 2

ER -